Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1989 4
1990 4
1991 6
1992 11
1993 18
1994 8
1995 16
1996 13
1997 11
1998 11
1999 13
2000 18
2001 15
2002 10
2003 17
2004 19
2005 26
2006 19
2007 28
2008 41
2009 42
2010 40
2011 40
2012 45
2013 60
2014 93
2015 98
2016 113
2017 145
2018 124
2019 140
2020 175
2021 166
2022 15
Text availability
Article attribute
Article type
Publication date

Search Results

1,389 results
Results by year
Filters applied: . Clear all
Page 1
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial.
Mann DL, Greene SJ, Givertz MM, Vader JM, Starling RC, Ambrosy AP, Shah P, McNulty SE, Mahr C, Gupta D, Redfield MM, Lala A, Lewis GD, Mohammed SF, Gilotra NA, DeVore AD, Gorodeski EZ, Desvigne-Nickens P, Hernandez AF, Braunwald E; LIFE Investigators. Mann DL, et al. JACC Heart Fail. 2020 Oct;8(10):789-799. doi: 10.1016/j.jchf.2020.05.005. Epub 2020 Jun 10. JACC Heart Fail. 2020. PMID: 32641226 Free PMC article. Clinical Trial.
The PARADIGM-HF (Prospective Comparison of Angiotensin II Receptor Blocker Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure) trial reported that sacubitril/valsartan (S/V), an an …
The PARADIGM-HF (Prospective Comparison of Angiotensin II Receptor Blocker Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor …
Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives.
Guglin M, Zucker MJ, Borlaug BA, Breen E, Cleveland J, Johnson MR, Panjrath GS, Patel JK, Starling RC, Bozkurt B; ACC Heart Failure and Transplant Member Section and Leadership Council. Guglin M, et al. J Am Coll Cardiol. 2020 Mar 31;75(12):1471-1487. doi: 10.1016/j.jacc.2020.01.034. J Am Coll Cardiol. 2020. PMID: 32216916 Free article. Review.
Timely referrals for transplantation and left ventricular assist device implantation play a key role in favorable outcomes in patients with advanced heart failure. Nonetheless, evaluation usually occurs at advanced heart failure centers and is obscured from r …
Timely referrals for transplantation and left ventricular assist device implantation play a key role in favorable outcomes in patient …
Cardiac rehabilitation and readmissions after heart transplantation.
Bachmann JM, Shah AS, Duncan MS, Greevy RA Jr, Graves AJ, Ni S, Ooi HH, Wang TJ, Thomas RJ, Whooley MA, Freiberg MS. Bachmann JM, et al. J Heart Lung Transplant. 2018 Apr;37(4):467-476. doi: 10.1016/j.healun.2017.05.017. Epub 2017 May 23. J Heart Lung Transplant. 2018. PMID: 28619383 Free PMC article.
BACKGROUND: Exercise-based cardiac rehabilitation (CR) is under-utilized. CR is indicated after heart transplantation, but there are no data regarding CR participation in transplant recipients. ...We identified heart transplant patients by diagn …
BACKGROUND: Exercise-based cardiac rehabilitation (CR) is under-utilized. CR is indicated after heart transplantation, but the …
Management of Patients With Giant Cell Myocarditis: JACC Review Topic of the Week.
Bang V, Ganatra S, Shah SP, Dani SS, Neilan TG, Thavendiranathan P, Resnic FS, Piemonte TC, Barac A, Patel R, Sharma A, Parikh R, Chaudhry GM, Vesely M, Hayek SS, Leja M, Venesy D, Patten R, Lenihan D, Nohria A, Cooper LT. Bang V, et al. J Am Coll Cardiol. 2021 Mar 2;77(8):1122-1134. doi: 10.1016/j.jacc.2020.11.074. J Am Coll Cardiol. 2021. PMID: 33632487 Review.
Giant cell myocarditis is a rare, often rapidly progressive and potentially fatal, disease due to T-cell lymphocyte-mediated inflammation of the myocardium that typically affects young and middle-aged adults. Frequently, the disease course is marked by acute heart failure, …
Giant cell myocarditis is a rare, often rapidly progressive and potentially fatal, disease due to T-cell lymphocyte-mediated inflammation of …
Fontan-Associated Liver Disease: Screening, Management, and Transplant Considerations.
Emamaullee J, Zaidi AN, Schiano T, Kahn J, Valentino PL, Hofer RE, Taner T, Wald JW, Olthoff KM, Bucuvalas J, Fischer R. Emamaullee J, et al. Circulation. 2020 Aug 11;142(6):591-604. doi: 10.1161/CIRCULATIONAHA.120.045597. Epub 2020 Aug 10. Circulation. 2020. PMID: 32776846 Free PMC article. Review.
Surveillance biopsies have demonstrated that virtually 100% of these patients develop clinically silent fibrosis by adolescence. As they mature, there are increasing reports of combined heart-liver transplantation resulting from advanced liver disease, including bri …
Surveillance biopsies have demonstrated that virtually 100% of these patients develop clinically silent fibrosis by adolescence. As they mat …
Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.
Epperla N, Li A, Logan B, Fretham C, Chhabra S, Aljurf M, Chee L, Copelan E, Freytes CO, Hematti P, Lazarus HM, Litzow M, Nishihori T, Olsson RF, Prestidge T, Saber W, Wirk B, Yared JA, Loren A, Pasquini M. Epperla N, et al. Br J Haematol. 2020 Jun;189(6):1171-1181. doi: 10.1111/bjh.16457. Epub 2020 Mar 2. Br J Haematol. 2020. PMID: 32124435 Free PMC article. Clinical Trial.
Transplant-associated thrombotic microangiopathy (TA-TMA) is a complication of allogeneic transplantation (allo-HCT). ...This study provides epidemiologic data on TA-TMA and its impact on transplant outcomes. Increased awareness of the risk factors will enabl
Transplant-associated thrombotic microangiopathy (TA-TMA) is a complication of allogeneic transplantation (allo-HCT). ...This
Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation.
Iske J, Seyda M, Heinbokel T, Maenosono R, Minami K, Nian Y, Quante M, Falk CS, Azuma H, Martin F, Passos JF, Niemann CU, Tchkonia T, Kirkland JL, Elkhal A, Tullius SG. Iske J, et al. Nat Commun. 2020 Aug 27;11(1):4289. doi: 10.1038/s41467-020-18039-x. Nat Commun. 2020. PMID: 32855397 Free PMC article.
Older organs represent an untapped potential to close the gap between demand and supply in organ transplantation but are associated with age-specific responses to injury and increased immunogenicity, thereby aggravating transplant outcomes. ...Collectively, we ident …
Older organs represent an untapped potential to close the gap between demand and supply in organ transplantation but are associated w …
American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support.
Kirklin JK, Pagani FD, Goldstein DJ, John R, Rogers JG, Atluri P, Arabia FA, Cheung A, Holman W, Hoopes C, Jeevanandam V, John R, Jorde UP, Milano CA, Moazami N, Naka Y, Netuka I, Pagani FD, Pamboukian SV, Pinney S, Rogers JG, Selzman CH, Silverstry S, Slaughter M, Stulak J, Teuteberg J, Vierecke J, Schueler S, D'Alessandro DA. Kirklin JK, et al. J Thorac Cardiovasc Surg. 2020 Mar;159(3):865-896. doi: 10.1016/j.jtcvs.2019.12.021. Epub 2020 Jan 23. J Thorac Cardiovasc Surg. 2020. PMID: 31983522 Review. No abstract available.
Reinnervation post-heart transplantation.
Grupper A, Gewirtz H, Kushwaha S. Grupper A, et al. Eur Heart J. 2018 May 21;39(20):1799-1806. doi: 10.1093/eurheartj/ehw604. Eur Heart J. 2018. PMID: 28087606 Review.
Heart transplantation results in complete denervation of the donor heart with loss of afferent and efferent nerve connections. The majority of patients remain completely denervated during the first 6-12 months following transplantation. Evidence of rei
Heart transplantation results in complete denervation of the donor heart with loss of afferent and efferent nerve conne
Neurological Complications in Patients with Heart Transplantation.
Sakusic A, Rabinstein AA. Sakusic A, et al. Semin Neurol. 2021 Aug;41(4):447-452. doi: 10.1055/s-0041-1726285. Epub 2021 Apr 13. Semin Neurol. 2021. PMID: 33851398 Review.
Neurological complications after heart transplantation are common and include cerebrovascular events (ischemic strokes, hemorrhagic strokes, and transient ischemic attacks), seizures, encephalopathy, central nervous system (CNS) infections, malignancies, and periphe …
Neurological complications after heart transplantation are common and include cerebrovascular events (ischemic strokes, hemorr …
1,389 results